Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Gains from Investment Securities (2016 - 2025)

Adma Biologics' Gains from Investment Securities history spans 11 years, with the latest figure at $1.9 million for Q3 2025.

  • For Q3 2025, Gains from Investment Securities rose 627.07% year-over-year to $1.9 million; the TTM value through Sep 2025 reached $1.9 million, up 627.07%, while the annual FY2024 figure was $3.3 million, 37.11% up from the prior year.
  • Gains from Investment Securities reached $1.9 million in Q3 2025 per ADMA's latest filing, up from $1.8 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $2.8 million in Q2 2024 to a low of $1000.0 in Q4 2023.
  • Average Gains from Investment Securities over 5 years is $1.2 million, with a median of $1.7 million recorded in 2021.
  • Peak YoY movement for Gains from Investment Securities: crashed 99.38% in 2022, then surged 19221.22% in 2023.
  • A 5-year view of Gains from Investment Securities shows it stood at $8493.0 in 2021, then grew by 2.66% to $8719.0 in 2022, then tumbled by 88.53% to $1000.0 in 2023, then soared by 25686.7% to $257867.0 in 2024, then skyrocketed by 627.07% to $1.9 million in 2025.
  • Per Business Quant, the three most recent readings for ADMA's Gains from Investment Securities are $1.9 million (Q3 2025), $1.8 million (Q2 2025), and $1.7 million (Q1 2025).